US Patent Issued to IOLYX THERAPEUTICS on Sept. 22 for "Ophthalmic pharmaceutical compositions of roflumilast" (California Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,941, issued on Sept. 22, was assigned to IOLYX THERAPEUTICS INC. (Burlingame, Calif.).

"Ophthalmic pharmaceutical compositions of roflumilast" was invented by Richard Graham (Irvine, Calif.), Hovhannes J. Gukasyan (Orange, Calif.), Elizabeth W. Jeffords (Hillsborough, Calif.) and Bhaskar Chaudhuri (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to stable, ophthalmic pharmaceutical formulations of the phosphodiesterase-4 inhibitor, roflumilast, and methods of making the same. Novel ophthalmic pharmaceutical formulations of roflumilast can comprise a viscosity agent, a surfactant, and a buffer. In prefer...